Hansa Biopharma — Juli 2022
-
Hanza Q2’22: Significantly Above Preliminary Figures (Redeye)
"Redeye will likely increase its forecasts and Base Case following a strong Q2 report, with numbers significantly above the preliminary figures. While Main Markets matched our forecasts more or less, Other Markets outperformed our expectations significantly, indicating the investments are paying off."
https://www.redeye.se/research/849499/hanza-q222-significantly-above-preliminary-figures
-
"While Main Markets came in as expected in terms of EBITA, Other Markets EBITA beat our expectations by over 100%. After some quarters with soft margins (Q1 was 1.3%, for example), Q2 strongly indicates that the investments in Other Markets have started to pay off."
-
(-: Glasset er vist halvt fyldt.
-
Tror i kigger på den forkerte Hansa
Hanza er et helt andet firma…. HANZA Holding is a manufacturing company. The company delivers complete manufacturing solutions in mechanics, electronics, cabling, and final assembly. -
Men lidt ro på markedet og hvis Bank of America stopper med deres “julelege” så kan det gå hurtigt opad igen… BofA Securities Europe SA.
-36.938 -
Ha,ha, du har vist ret Aps, sådan går det når man er lidt for hurtig
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind